goralatide has been researched along with Myocardial Infarction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, H; Kim, JH; Kim, SH; Lee, J; Park, Y; Song, M; Sun, K | 1 |
| Li, M; Ma, X; Yuan, Y; Zhang, Y; Zhang, Z | 1 |
| Davies, NH; Poglitsch, M; Sharp, S; Sturrock, ED; Zilla, P | 1 |
| Carretero, OA; Cingolani, O; Liu, YH; Rhaleb, NE; Xu, J; Yang, F; Yang, XP | 1 |
| Cavasin, MA | 1 |
| Riley, PR; Rossdeutsch, A; Smart, N | 1 |
2 review(s) available for goralatide and Myocardial Infarction
| Article | Year |
|---|---|
Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
Topics: Animals; Heart; Humans; Models, Biological; Myocardial Infarction; Myocardium; Oligopeptides; Thymosin; Ventricular Remodeling | 2006 |
Thymosin beta4 and Ac-SDKP: tools to mend a broken heart.
Topics: Animals; Cardiotonic Agents; Humans; Myocardial Infarction; Oligopeptides; Thymosin | 2008 |
4 other study(ies) available for goralatide and Myocardial Infarction
| Article | Year |
|---|---|
Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP.
Topics: Animals; Biocompatible Materials; Cells, Cultured; Chemokine CXCL12; Drug Synergism; Gene Expression; Humans; Hydrogels; Male; Mesenchymal Stem Cells; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Regeneration; Transcriptome; Ventricular Function, Left | 2014 |
An analog of Ac-SDKP improves heart functions after myocardial infarction by suppressing alternative activation (M2) of macrophages.
Topics: Animals; Macrophage Activation; Macrophages; Mice; Myocardial Infarction; Oligopeptides; Rats | 2014 |
Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Lisinopril; Male; Metabolome; Myocardial Infarction; Oligopeptides; Peptides; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Rats, Wistar; Renin-Angiotensin System | 2015 |
Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Cardiac Output, Low; Cell Movement; Collagen; Fibrosis; Heart; Heart Rate; Inflammation; Macrophages; Male; Myocardial Infarction; Myocardium; Oligopeptides; Rats; Rats, Inbred Lew; Transforming Growth Factor beta | 2004 |